|
Market Closed -
Deutsche Boerse AG
15:55:02 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 334.00 EUR | +0.60% |
|
-4.57% | +53.14% |
| 09-17 | CVS Health's Aetna to streamline cancer treatment approvals | RE |
| 09-11 | BofA Adjusts Price Target on Humana to $510 From $500 | MT |
Company Valuation: Humana Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 59,622 | 64,843 | 56,361 | 30,550 | 30,806 | 46,377 | - | - |
| Change | - | 8.76% | -13.08% | -45.8% | 0.84% | 50.55% | - | - |
| Enterprise Value (EV) 1 | 68,722 | 70,908 | 63,323 | 40,050 | 38,975 | 53,884 | 52,788 | 50,711 |
| Change | - | 3.18% | -10.7% | -36.75% | -2.68% | 38.25% | -2.03% | -3.93% |
| P/E | 20.5x | 23.2x | 22.9x | 25.4x | 26x | 53.9x | 23.8x | 15.4x |
| PBR | 3.73x | 4.18x | 3.44x | 1.87x | 1.75x | 2.64x | 2.34x | 2.03x |
| PEG | - | -8.91x | -2.43x | -0.5x | -18.53x | -2x | 0x | 0.3x |
| Capitalization / Revenue | 0.72x | 0.7x | 0.53x | 0.26x | 0.24x | 0.28x | 0.28x | 0.26x |
| EV / Revenue | 0.83x | 0.76x | 0.6x | 0.34x | 0.3x | 0.33x | 0.31x | 0.28x |
| EV / EBITDA | 16.1x | 13.8x | 11.1x | 9.97x | 9.45x | 19x | 13x | 9.12x |
| EV / EBIT | 27.6x | 16.1x | 12.7x | 11.3x | 14.4x | 24.9x | 16.3x | 10.4x |
| EV / FCF | 72.6x | 20.5x | 21.3x | 16.8x | 104x | 18.7x | 16.3x | 11.9x |
| FCF Yield | 1.38% | 4.89% | 4.7% | 5.97% | 0.96% | 5.36% | 6.14% | 8.39% |
| Dividend per Share 2 | 2.725 | 3.15 | 3.54 | 3.54 | 3.54 | 3.684 | 3.793 | 3.823 |
| Rate of return | 0.59% | 0.62% | 0.77% | 1.4% | 1.38% | 0.95% | 0.98% | 0.99% |
| EPS 2 | 22.67 | 22.08 | 20 | 9.98 | 9.84 | 7.161 | 16.24 | 25.03 |
| Distribution rate | 12% | 14.3% | 17.7% | 35.5% | 36% | 51.4% | 23.4% | 15.3% |
| Net sales 1 | 83,064 | 92,870 | 106,374 | 117,761 | 129,664 | 162,768 | 168,537 | 179,850 |
| EBITDA 1 | 4,278 | 5,122 | 5,711 | 4,016 | 4,124 | 2,834 | 4,054 | 5,560 |
| EBIT 1 | 2,488 | 4,413 | 4,999 | 3,543 | 2,704 | 2,160 | 3,235 | 4,868 |
| Net income 1 | 2,933 | 2,806 | 2,489 | 1,207 | 1,188 | 885.9 | 2,017 | 3,012 |
| Net Debt 1 | 9,100 | 6,065 | 6,962 | 9,500 | 8,169 | 7,506 | 6,410 | 4,334 |
| Reference price 2 | 463.86 | 512.19 | 457.81 | 253.71 | 256.13 | 386.22 | 386.22 | 386.22 |
| Nbr of stocks (in thousands) | 128,534 | 126,600 | 123,111 | 120,411 | 120,273 | 120,080 | - | - |
| Announcement Date | 2/2/22 | 2/1/23 | 1/25/24 | 2/11/25 | 2/11/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 20.44x | 0.86x | 13.02x | 2.44% | 338B | ||
| 19.83x | 0.57x | 10.78x | 1.68% | 89.12B | ||
| 11.03x | 0.33x | 7.11x | 2.24% | 72.74B | ||
| 53.93x | 0.33x | 19.01x | 0.95% | 46.38B | ||
| 16.97x | 0.14x | 9.57x | -.--% | 32.16B | ||
| 68.16x | 0.21x | 12.94x | -.--% | 10.46B | ||
| 78.99x | 0.78x | 28.84x | -.--% | 2.37B | ||
| 21.09x | 1.39x | 8.07x | -.--% | 2.08B | ||
| 46.09x | 0.25x | 8.4x | -.--% | 1.73B | ||
| Average | 37.39x | 0.54x | 13.08x | 0.81% | 66.15B | |
| Weighted average by Cap. | 22.77x | 0.66x | 12.28x | 1.99% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- HUM Stock
- HUM Stock
- Valuation Humana Inc.
Select your edition
All financial news and data tailored to specific country editions
















